Action of L-Dopa in drug induced extrapyramidalism.
D000328:Adult; D002746:Chlorpromazine / Q000009:adverse effects; D002908:Chronic Disease; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage*; D005116:Extrapyramidal Tracts; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy*; D010546:Perphenazine / Q000009:adverse effects; D012559:Schizophrenia / Q000188:drug therapy; D012907:Smoking; D014268:Trifluoperazine / Q000009:adverse effects; D014282:Trihexyphenidyl / Q000627:therapeutic use
D014268:Trifluoperazine; D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D010546:Perphenazine; D002746:Chlorpromazine